Urticaria. Urticaria
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with clinically chronic urticaria according to the 2018 EAACI/GA2LEN/EDF/WAO guidelines
Exclusion criteria
Exclusion criteria: Immunodeficient patients Users of corticosteroids or drug-affected immune system Abnormal thyroid tests Drug abuse Pregnancy and breastfeeding Simultaneous use of herbal drugs or traditional medical treatments such as cupping or phlebotomy or leech therapy or local drugs No tendency to cooperate in the research Occurrence of possible clinical complications such as asthma Alcoholics
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The score of severity of urticaria according to Urticaria Severity Score table. Timepoint: Measuring the intensity of urticaria on days 0-14-30 of the intervention. Method of measurement: UAS7 (urticaria activity score 7) questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: Before and after the intervention (end of the first month). Method of measurement: The quality of life questionnaire score of patients with chronic urticaria (Persian version).;Serological tests including IgE, eosinophil, C-reactive protein, ESR, interleukin (IL)-4, IL-63. Timepoint: Before and after the intervention (end of the first month). Method of measurement: laboratory.;Changing the need to take urticaria drugs. Timepoint: Before and after the intervention (end of the first month). Method of measurement: data collection form. | — |
Countries
Iran (Islamic Republic of)
Contacts
Mashhad University of Medical Sciences